<unk>  is used in combination with other antiemetic (anti-vomiting) agents in adults for the prevention of delayed nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy, including, but not limited to, highly emetogenic chemotherapy. The approved antiemetic combination consists of<unk>  plus dexamethasone and a 5-HT3 antagonist.
Rolapitant
Ezlopitant
Terguride
Telmisartan
Isosorbide dinitrate
Mitapivat
Cobicistat
Eluxadoline